Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process
Valo to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference
Valo Announces Exclusive Partnership with G3 the World's Largest and Detailed Cardio-Metabolic Datasets Valo identifies subpopulations across the cardiometabolic spectrum that have not been identified previously
Valo Health Adds Award-Winning Neurobiologist Virginie Buggia-Prevot Ph.D. and Computational Scientist Andrea Rossi Ph.D.
Flagship Pioneering Announces Valo Health to Transform Drug Development Valo integrates machine learning, cloud computing, and data to create a new drug discovery and development process that can shave years off timelines and improve the likelihood of s